Literature DB >> 12119449

Neurotransmitter mechanisms in gabapentin antinociception.

R K Dixit1, V K Bhargava.   

Abstract

The present study was done to investigate the neurotransmitter mechanisms involved in gabapentin antinociception in healthy albino rats. The formalin test was used to asses antinociception. Gabapentin (10-120 mg/kg s.c.) decreased the pain score in the formalin test. In order to study the putative neurotransmitter mechanisms involved in gabapentin action, the effect of gabapentin (30 mg/kg s.c.) alone and in rats pretreated with different receptor blockers, e.g. bicuculine, saclofen, naloxone, mecamylamine, atropine, DL-p-chlorophenylalanine methyl ester hydrochloride, glibenclamide, theophylline, and L-arginine was assessed. Gabapentin decreased the pain score, and the ED(50) of gabapentin was 36.8 +/- 8.2 (30.2-43.1) mg/kg s.c. Pretreatment with different receptor blockers did not modify gabapentin (30 mg/kg s.c.) antinociception except for L-arginine which increased the pain score from 1.68 +/- 0.29 (gabapentin) to 2.29 +/- 0.41. Results suggest the involvement of L-arginine nitric oxide pathways in gabapentin antinociception. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119449     DOI: 10.1159/000064344

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

Review 1.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

2.  Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.

Authors:  Keiko Takasu; Motoko Honda; Hideki Ono; Mitsuo Tanabe
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

3.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

4.  Gabapentin Reduces Blood Pressure and Heart Rate through the Nucleus Tractus Solitarii.

Authors:  Hsin-Hung Chen; Yih-Do Li; Pei-Wen Cheng; Yi-Chien Fang; Chi-Cheng Lai; Ching-Jiunn Tseng; Jun-Yen Pan; Tung-Chen Yeh
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

5.  Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies.

Authors:  Fatma Sultan Kilic; Basar Sirmagul; Engin Yildirim; Setenay Oner; Kevser Erol
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

6.  A 3D Tissue Model of Traumatic Brain Injury with Excitotoxicity That Is Inhibited by Chronic Exposure to Gabapentinoids.

Authors:  Nicolas Rouleau; Mattia Bonzanni; Joshua D Erndt-Marino; Katja Sievert; Camila G Ramirez; William Rusk; Michael Levin; David L Kaplan
Journal:  Biomolecules       Date:  2020-08-17

7.  Nitric oxide activates ATP-sensitive potassium channels in mammalian sensory neurons: action by direct S-nitrosylation.

Authors:  Takashi Kawano; Vasiliki Zoga; Masakazu Kimura; Mei-Ying Liang; Hsiang-En Wu; Geza Gemes; J Bruce McCallum; Wai-Meng Kwok; Quinn H Hogan; Constantine D Sarantopoulos
Journal:  Mol Pain       Date:  2009-03-14       Impact factor: 3.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.